Skip to content

Home Map The News Technology Politics Business Sports Entertainment Science Health World

Global AI-Powered News Intelligence. Real-time headlines, mapped by continent and country, from news sources worldwide.

Powered by AI

Navigate

Home
Map The News
About
Sources & methodology
Sources & methodology
Search

Sections

Technology
Politics
Business
Sports
Entertainment
Science

More

Privacy
Contact
Sitemap
Robots

© 2026 newsGlobal. All rights reserved.

Headlines refresh every 10 minutes.

Home Map Search Topics About

Home / Business

Business

Owkin signs AI drug discovery deal with Boehringer for cancer, immunology

CNA

BusinessCNA·Sep 2, 2026·1 min read

Owkin signs AI drug discovery deal with Boehringer for cancer, immunology

Full body text is not yet available for this story. Tap “View original source” below to read it on the publisher’s site.

View original source — CNA ↗

ShareShare on X Share on Facebook

Related stories

BusinessSep 2, 2026 · 1 min

Boehringer Signs Deal for Owkin AI, Joining Astra and Sanofi

GSK in talks to buy cancer biotech Nuvalent for more than $9bn

Financial Times

HealthJun 9, 2026 · 1 min

GSK in talks to buy cancer biotech Nuvalent for more than $9bn

Financial Times

AbbVie would gain an experimental eczema drug by buying biotech: report

HealthJun 20, 2026 · 1 min

AbbVie would gain an experimental eczema drug by buying biotech: report

GSK Agrees to Buy Nuvalent for $10.6 Billion

HealthJun 9, 2026 · 1 min

GSK Agrees to Buy Nuvalent for $10.6 Billion